Aortic thrombosis as a dramatic vascular complication in COVID-19 disease.
J Med Vasc
; 47(4): 169-174, 2022 Oct.
Article
in English
| MEDLINE | ID: covidwho-2061494
ABSTRACT
OBJECTIVE:
To report clinical outcomes of COVID-19 related acute aortic thrombosis (AAT).METHODS:
Consecutive COVID-19 patients presenting with AAT between April 2020 and August 2021 were included retrospectively. Clinical and radiological data were prospectively collected.RESULTS:
Ten patients (men, 90%; mean age, 64 ± 2 years) were included. At the time of AAT diagnosis, four patients were in intensive care unit. Median time between diagnosis of COVID-19 and AAT was 5 days [IQR 0-8.5]. Clinical presentation was acute lower limb ischaemia (n=9) and mesenteric ischaemia (n=2). Thrombus localization was the abdominal aorta (n=5), the thoracic aorta (n=2) or both (n=3), with the following embolic sites lower limbs (n=9), renal arteries (n=3), superior mesenteric artery (n=2), splenic artery (n=1), cerebral arteries (n=1). Revascularization was performed in 9 patients, using open (n=6), endovascular (n=2) or hybrid techniques (n=1). Three patients required reinterventions. The 30-day mortality was 30%. Three major amputations were performed in two patients, resulting in a free-amputation survival rate of 50% after a median follow-up of 3,5 months [IQR 2-4.1].CONCLUSION:
AAT is a rare and devastating complication of COVID-19 disease, responsible for high mortality and amputation rates.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Aortic Diseases
/
Arterial Occlusive Diseases
/
Thrombosis
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Med Vasc
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS